Analysis set for each outcome and definition.

<div><p>Introduction</p><p>Neurologic or immune-mediated conditions have been evaluated as potential adverse events (AEs) in coronavirus disease 2019 (COVID-19) vaccine safety surveillance. To contextualize United States (US) surveillance findings, it is important to quantify...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
1. autor: Shelby S. Fisher (22676406) (author)
Kolejni autorzy: Arnstein Lindaas (22676409) (author), Stella G. Muthuri (5395769) (author), Patricia C. Lloyd (18453529) (author), Joann F. Gruber (18453535) (author), Morgan M. Richey (21253213) (author), Hai Lyu (22676412) (author), Angela S. Cheng (22676415) (author), Lisa S. Kowarski (22676418) (author), Mollie M. McKillop (9111996) (author), Christine Bui (21253201) (author), Tainya C. Clarke (12892921) (author), Jeffrey Beers (22676421) (author), Timothy Burrell (12892927) (author), Pablo Freyria Duenas (22676424) (author), Yangping Chen (16549866) (author), Minya Sheng (22676427) (author), Richard A. Forshee (18453553) (author), Steven A. Anderson (11865398) (author), Yoganand Chillarige (18453556) (author), Mary S. Anthony (13922319) (author), Azadeh Shoaibi (11060528) (author), J. Bradley Layton (9756019) (author)
Wydane: 2025
Hasła przedmiotowe:
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy